Potential Involvement of the IL-6/JAK/STAT3 Pathway in the Pathogenesis of Intervertebral Disc Degeneration

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Spine

• Publication date

  2017-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/BRS.0000000000001982PMID 27879577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases

  2016cited by this paper
• Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration.

  2016cited by this paper
• A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients

  2016cited by this paper
• Excessive reactive oxygen species are therapeutic targets for intervertebral disc degeneration

  2015cited by this paper
• The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.

  2015cited by this paper
• Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedside.

  2015cited by this paper
• Expression of the JAK/STAT3/SOCS3 signaling pathway in herniated lumbar discs.

  2014cited by this paper
• Role of cytokines in intervertebral disc degeneration: pain and disc content

  2014cited by this paper
• Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration

  2014cited by this paper
• Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway.

  2012cited by this paper
• Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica

  2012cited by this paper
• Time course investigation of intervertebral disc degeneration produced by needle-stab injury of the rat caudal spine: laboratory investigation.

  2011cited by this paper
• CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes

  2011cited by this paper
• Pro-inflammatory, Pleiotropic, and Anti-inflammatory TNF-α, IL-6, and IL-10 in Experimental Porcine Intervertebral Disk Degeneration

  2009cited by this paper
• CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders.

  2009cited by this paper
• Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration.

  2009cited by this paper
• Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

  2009cited by this paper
• Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration

  2009cited by this paper
• Expenditures and health status among adults with back and neck problems.

  2008cited by this paper
• Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

  2008cited by this paper
• Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis

  2008cited by this paper
• Stab Incision for Inducing Intervertebral Disc Degeneration in the Rat

  2007cited by this paper
• Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile

  2007cited by this paper
• Effects of Cyclic Mechanical Stress on the Production of Inflammatory Agents by Nucleus Pulposus and Anulus Fibrosus Derived Cells In Vitro

  2006cited by this paper
• Interleukin-6: discovery of a pleiotropic cytokine

  2006cited by this paper
• Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor

  2004cited by this paper
• Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

  2003cited by this paper
• Degeneration of the intervertebral disc

  2003cited by this paper
• JAK/STAT but Not ERK1/ERK2 Pathway Mediates Interleukin (IL)-6/Soluble IL-6R Down-regulation of Type II Collagen, Aggrecan Core, and Link Protein Transcription in Articular Chondrocytes

  2003cited by this paper
• IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

  2002cited by this paper
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

  2000cited by this paper
• Intervertebral Disc Cell Death Is Dependent on the Magnitude and Duration of Spinal Loading

  2000cited by this paper
• Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

  1998cited by this paper
• The MAPK signaling cascade

  1995cited by this paper
• Herniated Cervical Intervertebral Discs Spontaneously Produce Matrix Metalloproteinases, Nitric Oxide, Interleukin‐6, and Prostaglandin E2

  1995cited by this paper
• Impaired immune and acute-phase responses in interleukin-6-deficient mice

  1994cited by this paper
• Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

  1988cited by this paper

• POSTN drives STAT3/NF-κB-mediated CXCL5 feedback to promote macrophage polarization in IDD.

  2025cites this paper
• Targeting the ROS-ferroptosis-inflammation cycle with a nanozyme-functionalized hydrogel for intervertebral disc repair

  2025cites this paper
• Effect of Massage on Regulating Oxidative Stress in Intervertebral Disc Degeneration in a Rat Model.

  2025cites this paper
• HSP90 inhibitors beyond oncology: optimization and mechanism insights in non-oncological diseases.

  2025cites this paper
• Identification of biomarkers related to neutrophil extracellular traps and potential therapeutic drugs for rheumatoid arthritis using computational analysis

  2025cites this paper
• M2 macrophages activate the IL-10/JAK2/STAT3 pathway to induce pathological microangiogenesis in the nucleus pulposus exacerbating intervertebral disc degeneration

  2025cites this paper
• Investigation of MicroRNA-17 Expression, Tumor Necrosis Factor-α, and Interleukin-6 Levels in Lumbar Degenerative Disc Disease: Case–Control Study

  2025cites this paper
• The protective effect and experimental research progress of pleotropic statins in intervertebral disc degeneration

  2025cites this paper
• Role of macrophage in intervertebral disc degeneration

  2025cites this paper
• Humanin reduces nucleus pulposus cells ferroptosis to alleviate intervertebral disc degeneration: An in vitro and in vivo study

  2025cites this paper
• The correlation of sleep disorders with postoperative outcomes in spine surgery: A narrative review

  2025cites this paper
• The STAT3/S100A6/P53/SLC7A11 axis mediates intervertebral disc degeneration by regulating ferroptosis in nucleus pulposus cells and the metabolism of the extracellular matrix.

  2025cites this paper
• Lentinan attenuates histone deacetylation of SOCS1 promoter to remodel autophagy via JAK2/STAT3 pathway for the prevention of intervertebral disc degeneration.

  2025cites this paper
• Tissue engineering strategies for treating intervertebral disc degeneration

  2025cites this paper
• A Bibliometric Study of Interleukin Cytokines in the Treatment of Intervertebral Disc Degeneration

  2025cites this paper
• Immune microenvironment in intervertebral disc degeneration: pathophysiology and therapeutic potential

  2025cites this paper
• Immunological mechanisms and immunoregulatory strategies in intervertebral disc degeneration

  2025cites this paper
• Electroacupuncture improves apoptosis of nucleus pulposus cells via the IL-22/JAK2-STAT3 signaling pathway in a rat model of cervical intervertebral disk degeneration

  2024cites this paper
• Discogenic Low Back Pain: Anatomic and Pathophysiologic Characterization, Clinical Evaluation, Biomarkers, AI, and Treatment Options

  2024cites this paper
• Myricetin Restores Autophagy to Attenuate Lumbar Intervertebral Disk Degeneration Via Negative Regulation of the JAK2/STAT3 Pathway

  2024cites this paper
• Comparison of Unilateral and Bilateral Transforaminal Epidural Steroid Injections in Unilateral Lumbar Disc Herniation: A Randomized Controlled Trial

  2024cites this paper
• Identifying critical modules and biomarkers of intervertebral disc degeneration by using weighted gene co‐expression network

  2024cites this paper
• Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the FAERS Database

  2024cites this paper
• A Review: Methodologies to Promote the Differentiation of Mesenchymal Stem Cells for the Regeneration of Intervertebral Disc Cells Following Intervertebral Disc Degeneration

  2023cites this paper
• SOCS3 protein expression predicts the responses of advanced non-small cell lung cancer patients to platinum-based chemotherapy

  2023cites this paper
• Cytokine Imbalance as a Biomarker of Intervertebral Disk Degeneration

  2023cites this paper
• The Role of IL-6 and TMEM100 in Lumbar Discogenic Pain and the Mechanism of the Glycine-Serine-Threonine Metabolic Axis: A Metabolomic and Molecular Biology Study

  2023cites this paper
• Regulatory Effect of Inflammatory Mediators in Intervertebral Disc Degeneration

  2023cites this paper
• Pathogenesis and therapeutic implications of matrix metalloproteinases in intervertebral disc degeneration: A comprehensive review.

  2023cites this paper
• α-ketoglutaric acid ameliorates intervertebral disc degeneration by blocking the IL-6/JAK2/STAT3 pathway.

  2023cites this paper
• Mechanisms of tissue degeneration mediated by periostin in spinal degenerative diseases and their implications for pathology and diagnosis: a review

  2023cites this paper
• The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential

  2023cites this paper
• Diagnostic model based on key autophagy-related genes in intervertebral disc degeneration

  2023cites this paper
• HSP90 Inhibitor 17-AAG Attenuates Nucleus Pulposus Inflammation and Catabolism Induced by M1-Polarized Macrophages

  2022cites this paper
• Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration

  2022cites this paper
• The Potential Role of Cytokines in Diabetic Intervertebral Disc Degeneration

  2022cites this paper
• The involvement of immune system in intervertebral disc herniation and degeneration

  2022cites this paper
• Cyanidin attenuates the apoptosis of rat nucleus pulposus cells and the degeneration of intervertebral disc via the JAK2/STAT3 signal pathway in vitro and in vivo

  2022cites this paper
• Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review

  2022influential citation
• Is There Any Relationship between Plasma IL-6 and TNF-α Levels and Lumbar Disc Degeneration? A Retrospective Single-Center Study

  2022cites this paper
• DNMT3B decreases extracellular matrix degradation and alleviates intervertebral disc degeneration through TRPA1 methylation to inhibit the COX2/YAP axis

  2021cites this paper
• Resveratrol protects human nucleus pulposus cells from degeneration by blocking IL-6/JAK/STAT3 pathway

  2021cites this paper
• Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions

  2021cites this paper
• Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions

  2021influential citation
• Anisodamine Maintains the Stability of Intervertebral Disc Tissue by Inhibiting the Senescence of Nucleus Pulposus Cells and Degradation of Extracellular Matrix via Interleukin-6/Janus Kinases/Signal Transducer and Activator of Transcription 3 Pathway

  2020cites this paper
• Efficacy of hyaluronic acid on intervertebral disc inflammation: An in vitro study using notochordal cell lines and human disc cells

  2020cites this paper
• Gene polymorphisms and expression levels of interleukin-6 and interleukin-10 in lumbar disc disease: a meta-analysis and immunohistochemical study

  2020cites this paper
• Intradiscal Therapeutics for Degenerative Disc Disease

  2020cites this paper
• Preclinical ex-vivo Testing of Anti-inflammatory Drugs in a Bovine Intervertebral Degenerative Disc Model

  2020influential citation
• Inflammatory biomarkers in sera of patients with intervertebral disc degeneration

  2019cites this paper
• Potential involvement of semaphorin 3A in maintaining intervertebral disc tissue homeostasis

  2019cites this paper
• Dysregulation of STAT3 signaling is associated with endplate-oriented herniations of the intervertebral disc in Adgrg6 mutant mice

  2019cites this paper
• Homeostasis of the intervertebral disc requires regulation of STAT3 signaling by the adhesion G-protein coupled receptor ADGRG6

  2019cites this paper
• Mitochondrial Pathway Is Involved in Advanced Glycation End Products-Induced Apoptosis of Rabbit Annulus Fibrosus Cells

  2018cites this paper
• Significant association of IL-6-572G/C, IL-6-597G/A, and IL-6-174G/C polymorphisms and susceptibility to lumbar degenerative disease: A meta-analysis.

  2018cites this paper
• IL‐6/YAP1/β‐catenin signaling is involved in intervertebral disc degeneration

  2018cites this paper
• World Journal of Stem Cells

  year unknowncites this paper